Australia markets close in 3 hours 58 minutes

ImmunoGen, Inc. (IMGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.17+1.42 (+29.89%)
At close: 04:00PM EST
5.83 -0.34 (-5.51%)
After hours: 07:57PM EST
Full screen
Trade prices are not sourced from all markets
Previous close4.75
Open6.84
Bid5.81 x 3100
Ask5.86 x 900
Day's range5.76 - 6.91
52-week range4.72 - 10.88
Volume58,308,666
Avg. volume1,560,930
Market cap1.25B
Beta (5Y monthly)1.21
PE ratio (TTM)N/A
EPS (TTM)-0.36
Earnings date10 Feb 2022 - 14 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est9.64
  • Motley Fool

    Why ImmunoGen Stock Soared Today

    Shares of ImmunoGen (NASDAQ: IMGN) surged 30% on Tuesday after the biotech announced promising clinical trial results for its experimental ovarian cancer therapy, mirvetuximab. The trial was designed to assess the safety and efficacy of mirvetuximab in patients with a form of platinum-resistant ovarian cancer who were already treated with Avastin (bevacizumab), a leading therapy developed by Roche-owned Genentech. "Despite advances in the platinum-sensitive setting, most patients with ovarian cancer eventually develop platinum-resistant disease, for which there are limited treatment options, especially for those patients who have previously received bevacizumab," co-principal investigator Robert Coleman said in a press release.

  • Business Wire

    ImmunoGen Announces Proposed Public Offering of Common Stock

    WALTHAM, Mass., November 30, 2021--ImmunoGen Announces Proposed Public Offering of Common Stock

  • Motley Fool

    These 2 Nasdaq Biotechs Are Bucking the Market Downtrend

    The stock market saw its recent volatility continue on Tuesday morning, as ongoing concerns about longer-term impacts of new COVID-19 variants weighed on market sentiment. As of 11:30 a.m. ET, the Nasdaq Composite (NASDAQINDEX: ^IXIC) had given up early gains and was down 204 points to 15,579. Immunogen (NASDAQ: IMGN) and Molecular Technology (NASDAQ: MOLN) were big gainers on the Nasdaq Tuesday morning, and the news they announced could keep boosting their shares for some time to come.